REQUEST A DEMO
Total
USD $0.00
Search more companies

Medpacto, Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Medpacto, Inc. Profile Updated: April 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Medpacto, Inc. is based in South Korea, with the head office in Seoul. The enterprise currently operates in the Research and Development in Nanotechnology sector. Medpacto, Inc. was incorporated on June 19, 2013. There are currently 54 (2025) people employed by Medpacto, Inc.. From the latest financial highlights, Medpacto, Inc. reported a net sales revenue increase of 206.2% in Q12026. Its’ total assets recorded a negative growth of 18.65%. The net profit margin of Medpacto, Inc. increased by 495.57% in 2026.

Headquarters
92, Myeongdal-Ro, Seocho-Gu, Seoul
Seoul; Seoul;

Contact Details: Purchase the Medpacto, Inc. report to view the information.

Website: http://www.medpacto.com

Basic Information
Total Employees:
Purchase the Medpacto, Inc. report to view the information.
Outstanding Shares:
Purchase the Medpacto, Inc. report to view the information.
Registered Capital:
Purchase the Medpacto, Inc. report to view the information.
Financial Auditors:
Purchase the Medpacto, Inc. report to view the information.
Incorporation Date:
June 19, 2013
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)메드팩토
Company Performance
Financial values in the chart are available after Medpacto, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
206.2%
Total Operating Revenue
183.89%
Operating Profit
-10.76%
EBITDA
-13.64%
Net Profit/Loss for the Period
-11.95%
Total Assets
-18.65%
Total Equity
-22.07%
Operating Profit Margin
559.19%
Net Profit Margin
495.57%
Return on Equity (ROE)
-2.68%
Quick Ratio
-32.96%
Cash Ratio
-6.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?